Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
Accumulated Depreciation
Guizhou Xinbang Pharmaceutical Co Ltd
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Accumulated Depreciation
-¥1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Accumulated Depreciation
-¥5.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accumulated Depreciation
-¥2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accumulated Depreciation
-¥510.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accumulated Depreciation
-¥4.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accumulated Depreciation
-¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Accumulated Depreciation?
Accumulated Depreciation
-1.9B
CNY
Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Accumulated Depreciation amounts to -1.9B CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 1Y
-9%
Over the last year, the Accumulated Depreciation growth was -9%.